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Ken Offit’s book, Clinical Cancer Genetics: Risk Counseling
and Management, is a well-written reference for physicians
and counselors who work with families that are known or are
suspected to harbor hereditary cancer syndromes. Chapters
1–3 provide background information about cancer genetics
and cancer risk counseling; chapters 4 and 5 describe specific
hereditary cancer syndromes; chapter 6 discusses risk assess-
ment methodology; chapter 7 describes techniques of DNA
analysis; and chapters 8–10 discuss other aspects of the cancer
genetic counseling process, which include testing patients with
cancer, reproductive counseling, and the psychological, ethical,
and legal ramifications of testing. Some of the topic areas are
treated in greater detail than are others, with breast cancer
genetics and management (not surprisingly) receiving the most
attention.
Chapters 4 and 5 are, in my opinion, the most valuable
parts of the book. In a very readable style, these two chapters
describe many of the cancer syndromes, in terms of the un-
derlying genetic etiology, associated cancer risks, and sugges-
tions (or debates) about monitoring. Each section of the book
is heavily referenced, which allows readers to turn to primary
sources for more detailed information about a particular topic.
One overall weakness of the book is its confusing organiza-
tional structure, which can frustrate attempts to locate desired
information quickly . In addition, the interpretation of some
of the tables and figures can be a challenge, because of the
minimal text accompanying them. Offit does a nice job (pri-
marily in chapter 10) of detailing the complex issues that can
arise during the cancer genetic counseling process, although
the case presentations scattered throughout the book are fairly
simplistic. Overall, this is an excellent reference book for ge-
netic counselors and for other providers, especially those who
are new to clinical cancer genetics.
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